Nattokinase
Metabolic Health · Fibrinolytic enzyme
Tier C
Bottom line
Read Off Label grades Nattokinase as C (4.9/10) based on weak evidence, moderate benefit magnitude, and a low-med-risk safety profile.
Popularity surged post-COVID in 'microclot' protocols, though mechanism-to-clinical-benefit chain remains speculative there.
Studied, labeled, or reported-use context: 100-200 mg (2000-4000 FU) daily on empty stomach — OTC; not individualized guidance.
What the evidence says
Popularity surged post-COVID in 'microclot' protocols, though mechanism-to-clinical-benefit chain remains speculative there. Some quality products have modest BP-lowering data. Perioperative or anticoagulant co-exposure can increase bleeding risk.
Mechanism
Serine protease from Bacillus subtilis natto fermentation; degrades fibrin and may activate plasminogen; anecdotally reduces BP, improves blood rheology
Studied, labeled, or reported dose & route
100-200 mg (2000-4000 FU) daily on empty stomach
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Nattokinase's effects?
- Read Off Label rates the evidence for Nattokinase as Weak and the benefit magnitude as moderate, producing an overall grade of C (4.9/10). Popularity surged post-COVID in 'microclot' protocols, though mechanism-to-clinical-benefit chain remains speculative there.
- What safety findings are reported for Nattokinase?
- Nattokinase has a low-med risk profile in the database. Low-Med (bleeding risk — especially additive with anticoagulants/antiplatelets; some preparations show Lp(a) reduction signal) Legal status: OTC.
- What doses or routes are reported for Nattokinase?
- 100-200 mg (2000-4000 FU) daily on empty stomach This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Nattokinase work?
- Serine protease from Bacillus subtilis natto fermentation; degrades fibrin and may activate plasminogen; anecdotally reduces BP, improves blood rheology
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.